The cost of a GLP-1 depends first on your insurance coverage. On September 6, 2026, Novo Nordisk listed Wegovy self-pay prices ranging from $149 to $399 per month, depending on the form and offer terms.1 On the same date, Eli Lilly listed regular Zepbound self-pay prices ranging from $299 to $699 per month, depending on the dose.2 Your final price depends chiefly on coverage for the prescribed indication, dose, and product.
Insurance Coverage and the Starting Price
Insurance coverage has more influence on your GLP-1 cost than any other factor. A commercial plan may cover the prescription, exclude weight-management treatment, or cover the drug only for a particular indication.
Coverage alone does not tell you the final amount. Savings cards have eligibility rules and maximum benefits. Your dose also matters because Zepbound’s regular self-pay price rises across the published dose tiers.2
Without coverage, the manufacturer’s self-pay pharmacy becomes one purchase route. These published prices do not establish what a retail pharmacy will charge or what your individual insurance plan will pay.
Comparing only the lowest month leaves out whether you can maintain the prescription and whether follow-up shows that the plan is working for you.
| Route to the drug | What it costs | What that price includes | The catch |
|---|---|---|---|
| Wegovy self-pay via NovoCare Pharmacy | Figures read September 6, 2026: Wegovy pill starts at $149 per month for the 1.5 mg dose. New patients can pay $199 per month for the first two months under an offer running through December 31, 2026. The Wegovy pen starts at $199 per month for the first two months for new patients. Established patients pay $349 per month for doses up to 2.4 mg. The HD pen costs $399 per month.1 | Purchase through NovoCare Pharmacy without insurance or a savings offer.1 | The $199 offer is limited to new patients and expires December 31, 2026. Confirm the current NovoCare terms. |
| Zepbound self-pay via LillyDirect | Regular prices read September 6, 2026: $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, and $699 for each of the 10 mg, 12.5 mg, and 15 mg KwikPen tiers. Four single-dose vials cost $299. Additional taxes and fees may apply.2 | A one-month supply through LillyDirect.2 | A separate offer read September 6, 2026, can set 7.5 mg and higher at $449. It applies to the first purchase and continues only when the next fill occurs within 45 days. The offer allows up to 11 fills per calendar year and expires December 31, 2026. Confirm the current LillyDirect terms.2 |
| Commercial insurance with a savings card | Figures read September 6, 2026: Wegovy can cost as little as $25 per month. Covered Zepbound can cost as little as $25 for a one-, two-, or three-month fill. When commercial insurance does not cover Zepbound, KwikPen savings terms list prices as low as $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg and higher.1,2 | The prescription and the savings benefit allowed under the applicable card terms. | On terms read September 6, 2026, Wegovy savings are limited to $100 per month and exclude government plans. Covered Zepbound savings are limited to $100, $200, or $300 based on fill length, with an annual maximum of $1,300. Zepbound savings end December 31, 2026. Maximum savings for non-covered Zepbound vary by dose. Check the Wegovy terms or Zepbound terms.1,2 |
| Medicare | Eligible Medicare patients pay $50 per month for Wegovy through the Medicare GLP-1 Bridge program, based on terms read September 6, 2026.1 | Wegovy prescribed for weight loss to an eligible adult under the bridge program.1 | Eligibility conditions apply. Confirm the current Medicare GLP-1 Bridge terms. |
| Compounded product | No price published. We do not publish prices for products the FDA has not reviewed. | Terms depend on the prescriber and dispensing pharmacy. | The U.S. Food and Drug Administration does not review compounded drugs for safety, effectiveness, or quality before marketing.3 |
| A supervised program | The medication is a separate cost from the clinical program. | A program may include baseline labs, physician review, follow-up visits, and repeat testing. | Included services differ. Review the Opt Health membership details before comparing a program with a medication-only price. |
The Cheapest GLP-1 Without Insurance
Manufacturer self-pay channels give you a published price without relying on insurance coverage. Novo Nordisk states that insurance and a savings offer are not required for its listed NovoCare Pharmacy prices.1
For Wegovy figures read September 6, 2026, the pill starts at $149 per month for the 1.5 mg dose. New patients can pay $199 per month for the first two months under the limited offer. Established patients pay $349 per month for pen doses up to 2.4 mg, while the HD pen costs $399 per month.1 Confirm the current Wegovy self-pay terms.
Zepbound has a dose-based regular price ladder. On September 6, 2026, Lilly listed $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, and $699 for the 10 mg, 12.5 mg, and 15 mg KwikPen tiers.2 The four-vial one-month supply was $299 on the same date.2 Confirm the current regular prices.
Lilly’s separate purchase offer listed 7.5 mg and higher at $449 as of September 6, 2026. That figure applies to the first purchase and continues only when the next fill occurs within 45 days. It is capped at 11 fills per calendar year and expires December 31, 2026.2 Check the current offer conditions before treating $449 as your expected monthly cost.
Commercial Insurance Savings
Commercial insurance can reduce your prescription cost when your plan covers the drug and you meet the savings-card conditions. The advertised amount is only the starting point because each card limits how much the manufacturer will contribute.
Novo Nordisk listed Wegovy at as little as $25 per month on September 6, 2026. The offer applied to non-government commercial plans and carried a maximum saving of $100 per month.1 Confirm the current Wegovy card terms.
For commercial insurance that covered the Zepbound single-dose pen, Lilly listed a price as low as $25 for a one-, two-, or three-month fill on September 6, 2026. Maximum savings were $100, $200, and $300 based on fill length, with a separate annual maximum of $1,300. The card expires December 31, 2026.2
Commercial insurance without Zepbound coverage uses different KwikPen savings terms. On September 6, 2026, Lilly listed prices as low as $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg and higher. Maximum savings vary by dose, and savings end December 31, 2026.2 Check the current Zepbound card terms.
Insurance Denials and Appeals
An insurance denial can turn on the plan’s benefit design, the prescribed indication, or missing clinical documentation. Some plans exclude weight-management treatment entirely, while others require the prescriber to show that you meet the plan’s criteria.
An appeal gives your prescriber a formal route to submit your history, relevant lab results, diagnosis, and the reason for the prescription. The plan then reviews the additional information under its own rules.
Approval is never automatic, and no single timeline applies to every plan. An appeal is still a standard administrative step after a denial. Your prescriber can tell you which records support the request and whether another covered route makes more sense.
Costs Beyond the Prescription
A drug price is one line in the treatment cost. Baseline lab work, medical review, follow-up care, and repeat testing each answer a different question.
A 55+ biomarker panel can place the prescription decision in context across hormones, inflammation, cardiovascular risk, and more.
Baseline labs give your prescriber starting values before deciding whether a prescription is appropriate. Results must be read with your medical history and current medications because one isolated value rarely explains the full pattern.
The physician visit covers the decision that a pharmacy price cannot make. Your physician reviews whether the drug fits your health history, what should be monitored, and which findings could change the plan.
Follow-up visits show whether the treatment is working for you and whether the prescription should change or stop. They also give you a place to discuss side effects, adherence, and a monthly price that has become difficult to maintain.
Repeat testing tracks changes the scale cannot show. Weight is one data point. Lab trends give your physician another view of how your body is responding.
Novo Nordisk listed a $149 per month starting price for the 1.5 mg Wegovy pill on September 6, 2026. That figure covers the medication alone, so keep it on a separate line from the cost of supervised care.1 Confirm the current Wegovy figure, then use the membership details to identify which labs, visits, and follow-up services are included.
Monthly Price Across a Full Course
The cheapest month may not produce the lowest cost across a full course. Savings limits can leave you paying more than the advertised amount, and the Zepbound price changes across dose tiers.
Lilly’s regular prices illustrate the difference. A prescription at the 2.5 mg tier cost $299 per month on September 6, 2026. The listed 10 mg, 12.5 mg, and 15 mg tiers each cost $699 per month on the same date.2 If your prescription moves from the starting tier to one of the highest listed tiers, your regular monthly self-pay cost more than doubles. Confirm the current Zepbound price ladder.
A lower introductory figure also loses its value if the later price exceeds your budget. A drug you cannot continue paying for does not provide a sustainable treatment course. Ask your prescriber to discuss likely purchase routes before cost interrupts the plan.
The Purchase Route Without Insurance
Getting a GLP-1 without insurance still requires a prescriber and a valid prescription. Once prescribed, purchase routes can include a manufacturer self-pay pharmacy, a retail pharmacy, or a supervised program that keeps the medication charge separate.
The semaglutide weight-loss guide explains the drug itself. The semaglutide and tirzepatide comparison covers differences between the medications, while the GLP-1 guide for men covers physician-led treatment for men. If you are weighing hormone treatment at the same time, the TRT cost breakdown uses the same medication-plus-care framework.
The Opt Take on GLP-1 Cost
The membership covers the clinical work that every manufacturer price on this page leaves out: labs, physician review, and ongoing follow-up. The medication remains a separate cost.
We do not bill insurance, so compare the membership price with other cash-pay clinical programs rather than a pharmacy copay. We accept HSA/FSA. Foundation costs $95 per month and Optimization costs $245 per month, each with a one-time $195 intake and lab fee. Longevity costs $645 per month with a one-time $695 intake and lab fee.
Your initial panel includes 55+ biomarkers taken at home or at a local partner lab. An Opt Health physician reviews the results with you in a 1:1 consultation and sets your treatment plan. Existing conditions and current medications are part of that review. Follow-up labs and physician consultations repeat based on the membership tier, which allows the plan to change as your numbers and goals change.
The list price describes the drug purchase. Your total should also account for the physician-led care used to build, monitor, and adjust the plan.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Among the published manufacturer self-pay figures for Wegovy and Zepbound, Novo Nordisk’s Wegovy pill had the lowest starting price on September 6, 2026. The 1.5 mg dose started at $149 per month.1 Confirm the current NovoCare price.
That comparison does not include compounded products. The compounded semaglutide guide explains the regulatory record and the tradeoffs to review before choosing that route.
People without coverage may use manufacturer self-pay pharmacies, savings cards available to eligible commercial-insurance patients, or an insurance appeal after a denial. Dose can also change the monthly price, particularly under Zepbound’s regular self-pay ladder.2
An appeal may help when the denial involves the covered indication or missing documentation. Your prescriber can submit the relevant medical record and explain why the prescription was selected. The insurer applies its own benefit rules to that request.
You need a prescriber to review your health history and determine whether a GLP-1 prescription is appropriate. If you receive a prescription, you can compare the manufacturer self-pay channel with retail pharmacy access and a supervised program.
NovoCare Pharmacy publishes Wegovy self-pay terms, while LillyDirect publishes Zepbound regular prices and purchase offers.1,2 Keep the medication price separate from labs and follow-up care, then choose the route you can maintain under your physician’s plan.
Compare the full cost of care before choosing a monthly drug price. An Opt Health membership pairs comprehensive labs with a physician who reviews your results and adjusts your plan through ongoing follow-up. Medication remains a separate cost.
References
- Novo Nordisk. Wegovy savings and self-pay pricing. NovoCare. https://www.novocare.com/obesity/products/wegovy/savings-offer.html. Accessed September 6, 2026.
- Eli Lilly. Zepbound savings and self-pay pricing. https://zepbound.lilly.com/savings. Accessed September 6, 2026.
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss. Accessed September 6, 2026.
GLP-1 cost and offer terms can change without notice, so verify current figures on the NovoCare Wegovy pricing page and the Lilly Zepbound savings page before relying on them.
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.